Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus

Matthew J. Dreitz From the Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Matthew J. Dreitz in
Current site
Google Scholar
PubMed
Close
 BS
,
Steven W. Dow From the Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Steven W. Dow in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Susan A. Fiscus From the Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Susan A. Fiscus in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Edward A. Hoover From the Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Edward A. Hoover in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

SUMMARY

We generated monoclonal antibodies (mab) against feline immunodeficiency virus (fiv) and characterized these mab by single competition enzyme immunoassays (eia), immunoblot analysis, and radioimmunoprecipitation. Four mab identified 3 distinct epitopes of the fiv p24/26 gag major core protein. One mab recognized the pl6/17 gag protein; none recognized envelope proteins. We developed an fiv p26 antigen capture eia that proved more sensitive (0.5 ng of p26/ml), less expensive, and less timeconsuming than reverse transcriptase assay. The same mab were used to develop an antibody eia specific for fiv p26. The mab and capture assays reported should prove useful in fiv diagnosis and research.

SUMMARY

We generated monoclonal antibodies (mab) against feline immunodeficiency virus (fiv) and characterized these mab by single competition enzyme immunoassays (eia), immunoblot analysis, and radioimmunoprecipitation. Four mab identified 3 distinct epitopes of the fiv p24/26 gag major core protein. One mab recognized the pl6/17 gag protein; none recognized envelope proteins. We developed an fiv p26 antigen capture eia that proved more sensitive (0.5 ng of p26/ml), less expensive, and less timeconsuming than reverse transcriptase assay. The same mab were used to develop an antibody eia specific for fiv p26. The mab and capture assays reported should prove useful in fiv diagnosis and research.

Advertisement